Qiang Li, Ph.D., Postdoctoral FellowThe Rockefeller University

Thanks to the financial support from CRI, I can conduct important cancer immunology research, which holds great possibility for the cancer treatment in the future.
Area of Research: All cancers

Inflammation enables our immune system to root out infections, heal wounds, and even eliminate cancer. However, if inflammation becomes chronic or irregular, it can harm our healthy tissues and even support cancer. SPMs (specialized pro-resolving lipid mediators) are molecules that can help “de-escalate” inflammation by enhancing phagocytosis, the process of recycling cellular and molecular debris. However, it’s unknown how SPMs promote phagocytosis, so Dr. Li’s work is designing a way to track a specific SPM and identify what it binds to. After he’s identified potential targets, he plans to genetically modify cells to see how different genes impact inflammation signaling pathways. These insights could then guide strategies seeking to limit improper inflammation in patients with cancer and other diseases.

Projects and Grants

Chemical Biology of Anti-Inflammatory Lipids

The Rockefeller University | All Cancers | 2017 | Howard C. Hang, Ph.D.

Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.